Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Abbott said Wednesday that its first quarter Diagnostics business revenues grew about 2 percent year over year, driven by long-term double-digit growth in its Alinity molecular diagnostic platform and other products. For the three months end

University of Southern California (USC) scientists havemade an advancement in chimeric antigen receptor (CAR) T-cell therapy that seems to eliminate its severe side effects, making the treatment safer and potentially available in outpatient

On April 17, 2019, WuXi Biologics, a provider of end-to-end solutions for biologics discovery, development, and manufacturing, announced that its drug substance (DS) and drug product (DP) manufacturing facilities at WuXi city successfully co

Eli Lilly announced on April 22, 2019 that it has entered into an agreement with Eddingpharm, a China-based specialty pharmaceutical company, to sell rights to two of the Lillys antibiotic medicinesCeclor (cefaclor monohydrate) and Vancocin

What happens when a Next Generation Sequencing (NGS) company and anin vitrodiagnostics (IVD) Manufacturer join forces? The answer is stronger companion diagnostics that could help improve the efficiency of clinical trials. Cellgen Diagnostic

Traumatic brain injuries (TBI) or concussions contributed to about 30% of all injury deaths according to estimates from the Centers for Disease Control and Prevention. As a result, companies are working diligently to develop tests for the de

RocheGets Ventana in the End Roche went through a lot (and we do mean a lot) to acquire Ventana Medical Systems. The Basel, Switzerland-based company made offers and even tried a hostile takeover attempt to pick up the molecular diagnostics

Hologic Shines With Gen-Probe MA In 2012, Hologic was growing significantly in its diagnostics offerings. But the Marlborough, MA-based company needed a bit more. The firm remedied this situation by making a move to acquire Gen-Probe for $3.

The diagnostics space is rapidly changing and growing. In May,a sessionon Center Stage at MDM East will address some of these changes in the in vitro diagnostics market along with fast growth markets and disruptive trends. We haveidentified

Illumina and China firm Boai NKY Medical Holdings have partnered to develop next-generation sequencing-based hereditary disease tests in China. Under the agreement announced on Tuesday, NKY and Illumina will develop an NGS system based on I